Diseases of the Abdomen and Pelvis 2023-2026 : : Diagnostic Imaging.

Diseases of the Abdomen and Pelvis 2023-2026 : : Diagnostic Imaging.

Show other versions (1)
Saved in:
Bibliographic Details
Superior document:IDKD Springer Series
:
Hodler, Juerg.
TeilnehmendeR:
Kubik-Huch, Rahel A.
Roos, Justus E.
von Schulthess, , Gustav K.
Place / Publishing House:Cham : : Springer International Publishing AG,, 2023.
©2023.
Year of Publication:2023
Edition:1st ed.
Language:English
Series:IDKD Springer Series
Online Access:
Physical Description:1 online resource (287 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Intro
  • Contents
  • 1: Emergency Radiology of the Abdomen and Pelvis
  • 1.1 Trauma Part
  • 1.1.1 Role of Imaging to Assess Blunt Abdominal Polytrauma (BAT) Patients
  • 1.1.1.1 Primary Survey
  • 1.1.1.2 Secondary Survey
  • Imaging of Common Abdominal Traumatic Injuries
  • Intraperitoneal Fluid
  • Organ Injuries
  • Spleen Injuries
  • Liver Injuries
  • Urinary Tract Injuries
  • Bowel and Mesenteric Injuries
  • Diaphragmatic Injuries
  • Pancreatic Injuries
  • 1.2 Non-Traumatic Abdominal Pain
  • 1.2.1 Modalities
  • 1.2.2 Right Upper Quadrant
  • 1.2.2.1 Acute Cholecystitis
  • 1.2.2.2 Duodenal Ulcers
  • 1.2.3 Left Upper Quadrant
  • 1.2.3.1 Acute Pancreatitis
  • 1.2.3.2 Gastritis
  • 1.2.4 Right Lower Quadrant Pain
  • 1.2.4.1 Acute Appendicitis
  • 1.2.4.2 Cecal Inflammation
  • 1.2.4.3 Terminal Ileitis
  • 1.2.5 Left Lower Quadrant Pain
  • 1.2.5.1 Sigmoid Diverticulitis
  • 1.2.5.2 Epiploic Appendagitis
  • 1.2.5.3 Pelvic Pain: Endometriosis
  • 1.2.5.4 Ovarian Torsion
  • 1.2.6 Diffuse Abdominal Pain
  • 1.2.6.1 Small Bowel Obstruction
  • 1.2.6.2 Colonic Obstruction
  • 1.2.6.3 Acute Mesenteric Ischemia
  • 1.2.7 Concluding Remarks
  • References
  • 2: Imaging Infectious Disease of the Abdomen (Including COVID-19)
  • 2.1 Introduction
  • 2.2 Risk Factors for Infections
  • 2.2.1 Barrier Disruption
  • 2.2.2 Anatomic Obstruction
  • 2.2.3 Vascular Compromise
  • 2.2.4 Pre-existing Malignancy
  • 2.2.5 Immunosuppression
  • 2.2.6 Prior Radiation
  • 2.2.7 Medical Devices
  • 2.2.8 Surgery
  • 2.3 Imaging in Abdominal Infections
  • 2.3.1 Gastrointestinal Tract Infections
  • 2.3.1.1 Clostridioides Difficile Colitis
  • 2.3.1.2 Neutropenic Enterocolitis
  • 2.3.1.3 Gastrointestinal Tuberculosis
  • 2.3.1.4 Viral Enterocolitis
  • 2.3.1.5 Fungal Infections
  • 2.3.2 Hepatobiliary Infections
  • 2.3.2.1 Liver Abscesses.
  • 2.3.2.2 Cholangitis
  • 2.3.2.3 Viral Infections
  • 2.3.2.4 Parasitic Infections
  • 2.3.3 Genitourinary Tract Infections
  • 2.3.3.1 Obstructive Uropathy
  • 2.3.3.2 Renal and Urinary Bladder Infections
  • 2.3.3.3 Prostatic Infections
  • 2.3.4 Peritoneal and Abdominal Wall Infections
  • 2.3.4.1 Peritoneal Devices
  • 2.3.4.2 Intra-abdominal Abscesses
  • 2.3.4.3 Abdominal Wall Infections
  • 2.4 Conclusion
  • References
  • 3: Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging
  • 3.1 Introduction
  • 3.2 Introduction to Theranostics
  • 3.2.1 Therapeutic Radionuclides
  • 3.2.2 Unique Role of Dosimetry
  • 3.2.3 Current Theranostic Agents and Agents in Development
  • 3.2.4 Patient Selection for Internal Radiotherapy
  • 3.3 Monitoring Disease
  • 3.3.1 Response Based on Morphology
  • 3.3.2 Response Based on Morphology for Immunotherapy
  • 3.3.3 Response Based on FDG PET
  • 3.4 Monitoring Liver Disease After SIRT
  • 3.4.1 Monitoring SIRT with CT/MRI
  • 3.4.2 Monitoring SIRT with PET
  • 3.5 Monitoring Neuroendocrine Tumors
  • 3.6 Monitoring Metastasized Prostate Cancer
  • 3.6.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans
  • 3.6.2 Monitoring Metastasized Prostate Cancer with PET/CT
  • 3.7 The Role of MRI and PET/MRI for Response Evaluation
  • 3.8 Concluding Remarks
  • References
  • 4: Benign and Malignant Diseases of the Colon and Rectum
  • 4.1 Benign Diseases of the Colon and Rectum
  • 4.1.1 Inflammatory Diseases of the Colon and Rectum
  • 4.1.1.1 Chronic Inflammatory Bowel Diseases
  • 4.1.1.2 Infectious Colitis
  • Pseudomembranous Colitis
  • 4.1.1.3 Non-infectious Colitis
  • Ischemic Colitis
  • Drug-Induced Colitis
  • Neutropenic Colitis
  • Radiation Colitis and Proctitis
  • Graft-Versus-Host Disease
  • 4.1.2 Diverticular Disease and Diverticulitis.
  • 4.1.3 Benign Mucosal Colonic Polyp
  • 4.2 Malignant Diseases of the Colon and Rectum
  • 4.2.1 Rectal Cancer
  • 4.2.1.1 Elective Rectal Cancer Staging
  • 4.2.2 Colon Cancer
  • 4.2.2.1 Elective Colon Cancer Staging
  • 4.2.2.2 Colon Cancer Presenting as Acute Abdomen
  • 4.2.3 Evaluation of Response to Neoadjuvant Therapy in Rectal Cancer
  • 4.2.3.1 Technique
  • 4.2.3.2 Re-staging to Plan Surgery
  • 4.2.3.3 The Prognostic Value of Re-staging MR Imaging
  • 4.2.3.4 Re-staging to Select Patients for Non-operative Management
  • 4.3 Concluding Remarks
  • References
  • 5: Indeterminate Retroperitoneal Masses
  • 5.1 Introduction
  • 5.2 Retroperitoneal Space
  • 5.3 Tissue Diagnosis
  • 5.4 Adipocytic Tumors
  • 5.5 Other Soft-Tissue Sarcomas
  • 5.6 Neurogenic Tumors
  • 5.7 Miscellaneous
  • 5.8 Concluding Remarks
  • References
  • 6: Diffuse Liver Disease
  • 6.1 Metabolic and Storage Diseases
  • 6.1.1 Steatosis
  • 6.1.2 Iron Overload
  • 6.1.3 Wilson's Disease
  • 6.1.4 Amyloidosis
  • 6.1.5 Gaucher Disease
  • 6.2 Cirrhosis
  • 6.2.1 Imaging of Pre-stages of Cirrhosis
  • 6.2.2 Imaging of Cirrhosis
  • 6.3 Focal Lesions in Cirrhotic Liver
  • 6.3.1 Regenerative Nodules
  • 6.3.2 Dysplastic Nodules
  • 6.3.3 Malignant Lesions
  • 6.3.4 Confluent Focal Fibrosis
  • 6.3.5 Standardized Reporting with LI-RADS
  • 6.4 Diffuse Vascular Liver Disease
  • 6.4.1 Arteriovenous Shunts
  • 6.4.2 Budd-Chiari Syndrome
  • 6.4.3 Sinusoidal Obstruction Syndrome
  • 6.4.4 Passive Hepatic Congestion and Fontan-Associated Liver Disease
  • 6.4.5 Hereditary Hemorrhagic Telangiectasia (HHT)
  • 6.5 Diffuse Metastatic Disease
  • 6.6 Concluding Remarks
  • References
  • 7: Focal Liver Lesions
  • 7.1 Introduction
  • 7.2 MDCT Imaging Techniques
  • 7.3 MR Imaging Technique
  • 7.4 Benign Hepatic Lesions
  • 7.4.1 Cysts
  • 7.4.2 Hemangioma.
  • 7.4.3 Focal Nodular Hyperplasia (FNH)
  • 7.4.4 Hepatocellular Adenoma
  • 7.4.5 Biliary Hamartomas (von Meyenburg Complex)
  • 7.4.6 Hepatic Abscess and Echinococcus
  • 7.5 Malignant Primary Tumors
  • 7.5.1 Hepatocellular Carcinoma
  • 7.5.2 Fibrolamellar HCC
  • 7.5.3 Cholangiocellular Carcinoma
  • 7.6 Rare Primary Liver Tumors
  • 7.6.1 Biliary Cystadenoma/Cystadenocarcinomas
  • 7.6.2 Hepatic Angiosarcoma
  • 7.6.3 Epithelioid Hemangioendothelioma
  • 7.7 Hepatic Metastases
  • 7.8 Differential Diagnosis of Focal Liver Lesions
  • 7.9 Concluding Remarks
  • References
  • 8: Diseases of the Gallbladder and the Biliary Tree
  • 8.1 Biliary Tract
  • 8.1.1 Normal Anatomy and Variants
  • 8.1.2 Congenital Biliary Anomalies
  • 8.1.2.1 Choledochal Cysts and Anomalous Pancreatobiliary Ductal Junction
  • 8.1.3 Pathologic Conditions
  • 8.1.3.1 Choledocholithiasis
  • 8.1.3.2 Cholangitis
  • Suppurative Cholangitis
  • Pyogenic Cholangitis
  • Primary Sclerosing Cholangitis
  • 8.1.3.3 IgG4 Cholangitis
  • 8.1.3.4 Neoplasms of the Biliary System
  • Benign Tumors of the Bile Ducts
  • Hamartomas and adenomas
  • Biliary Intraepithelial Neoplasm and Intraductal Papillary Neoplasms of the Bile Ducts
  • Mucinous Cystic Neoplasms
  • Malignant Tumors of the Bile Ducts
  • Cholangiocarcinoma
  • Metastatic Disease
  • 8.2 Gallbladder
  • 8.2.1 Normal Anatomy
  • 8.2.2 Congenital Variants and Anomalies
  • 8.2.2.1 Agenesis of the Gallbladder
  • 8.2.2.2 Duplication of the Gallbladder
  • 8.2.2.3 Phrygian Cap of the Gallbladder
  • 8.2.2.4 Diverticula of the Gallbladder, Multiseptate Gallbladder, and Ectopic Gallbladder
  • 8.2.3 Pathologic Conditions
  • 8.2.3.1 Gallstones
  • 8.2.3.2 Acute Cholecystitis
  • 8.2.3.3 Acalculous Cholecystitis
  • 8.2.3.4 Chronic Cholecystitis
  • 8.2.3.5 Hyperplastic Cholecystosis
  • 8.2.3.6 Gallbladder Neoplasms
  • 8.3 Conclusion.
  • References
  • 9: Diseases of the Pancreas
  • 9.1 Developmental Anomalies of the Pancreas
  • 9.2 Pancreatic Neoplasms
  • 9.2.1 Pancreatic Carcinoma
  • 9.2.2 Other Tumors of Ductal Origin
  • 9.3 Cystic Neoplasm
  • 9.3.1 Serous Cystadenoma
  • 9.3.2 Mucinous Cystic Neoplasm (MCN)
  • 9.3.3 Intraductal Papillary Mucinous Neoplasm (IPMN)
  • 9.4 Other Neoplasm
  • 9.4.1 Neuroendocrine Tumors
  • 9.4.1.1 Insulinoma
  • 9.4.1.2 Gastrinoma
  • 9.4.2 Other Rare Pancreatic Neoplasm
  • 9.5 Inflammatory Diseases of the Pancreas
  • 9.5.1 Acute and Chronic Pancreatitis
  • 9.5.2 Autoimmune Pancreatitis
  • References
  • 10: Adrenal Diseases
  • 10.1 Introduction
  • 10.2 Incidental Adrenal Mass: No Underlying Malignancy
  • 10.2.1 Unenhanced CT
  • 10.2.2 CT Contrast-Washout
  • 10.2.3 Dual Energy CT
  • 10.2.4 MRI
  • 10.2.5 FDG PET/CT
  • 10.2.6 Lesion Morphology
  • 10.2.7 Adrenal Biopsy
  • 10.2.8 Management
  • 10.3 Evaluation of Adrenal Mass in Patient with Known Extra-Adrenal Malignancy
  • 10.4 Evaluation of Patient with Suspected Adrenal Hyperfunction
  • 10.4.1 Adrenal Cortical Hyperfunction
  • 10.4.2 Adrenal Medullary Hyperfunction
  • 10.5 Future Directions
  • 10.6 Concluding Remarks
  • References
  • 11: Benign and Malignant Renal Disease
  • 11.1 Introduction
  • 11.2 Modalities for Imaging Renal Masses
  • 11.2.1 Ultrasound (US) and Contrast-Enhanced US (CEUS)
  • 11.2.2 Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)
  • 11.3 Very Small Renal Masses (&lt
  • 1-1.5 cm)
  • 11.4 Cystic Renal Masses
  • 11.5 Angiomyolipoma (AML)
  • 11.6 Other Solid Renal Masses and Cancer Mimics
  • 11.6.1 Oncocytomas
  • 11.6.2 Renal Cell Cancers (RCCs)
  • 11.6.2.1 Clear Cell Renal Cell Cancer (ccRCC)
  • 11.6.2.2 Papillary Renal Cell Cancer (pRCC)
  • 11.6.2.3 Chromophobe Renal Cell Cancer (chRCC)
  • 11.6.2.4 Uncommon Renal Cancer Cell Types.
  • 11.6.3 Urothelial Neoplasms and Lymphoma.

Similar Items